Related Experiment Video
Updated: May 9, 2026
12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
The CD40/CD40L system: a new therapeutic target for disease
Bikui Zhang1, Tian Wu, Min Chen
1Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Immunology Letters
|July 30, 2013
Summary
CD40/CD40 ligand (CD40L) interactions are crucial in cardiovascular diseases and immune responses. Understanding these pathways and current CD40/CD40L drugs can lead to new treatments for various conditions.
Area of Science:
- Immunology
- Cardiovascular Biology
- Pharmacology
Background:
- CD40/CD40 ligand (CD40L) interactions play a recognized role in atherothrombosis, immune responses to pathogens, and thrombosis.
- These interactions are implicated in atherosclerosis (AS) pathogenesis, destabilizing plaques via cytokine and matrix metalloproteinase induction.
- CD40/CD40L signaling also influences immune system disorders, oxidative stress, and key signaling pathways in immunological and cardiovascular systems.
Purpose of the Study:
- To review the established roles of CD40/CD40L interactions in health and disease.
- To discuss current therapeutic strategies targeting the CD40/CD40L pathway.
- To highlight the potential for developing novel therapeutics based on understanding CD40/CD40L signaling.
Main Methods:
- Literature review of studies on CD40/CD40L interactions.
- Analysis of current drugs targeting the CD40/CD40L system.
- Discussion of signaling pathways regulated by CD40/CD40L.
Main Results:
- CD40/CD40L interactions significantly impact plaque stability, immune responses, and thrombosis.
- Current drugs targeting CD40/CD40L are being investigated for various therapeutic applications.
- Understanding CD40/CD40L regulation is key to developing new treatments.
Conclusions:
- CD40/CD40L interactions are central to multiple pathological processes.
- Targeting the CD40/CD40L pathway offers therapeutic potential for diverse diseases.
- Further research into CD40/CD40L signaling can drive innovation in drug development.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...